Gender differences are associated with the clinical features of systemic lupus erythematosus

Chinese Medical Journal

Volumn 125, Issue 14, 2012, Pages 2477-2481

  Ding, Yan ^a   He, Jing ^a   Guo, Jian Ping ^a   Dai, Yi Jun ^a   Li, Chun ^a   Feng, Min ^a   Li, Ru ^a   Li, Zhan Guo ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Gender; Male lupus; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; FOLLITROPIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUTEINIZING HORMONE; PRASTERONE; PROLACTIN; RO ANTIBODY; SM ANTIBODY; SMALL NUCLEAR RIBONUCLEOPROTEIN; TESTOSTERONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INCIDENCE; INFANT; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; ONSET AGE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84864212158     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.14.015     Document Type: Article

References (27)

1. Garcia MA, Marcos JC, Marcos AI, Pons-Estel BA, Wojdyla D, Arturi A, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 2005; 14: 938-946.
2. Mok CC, Lau CS, Chan TM, Wong RWS. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 1999; 8: 188-196.
3. Stahl NI, Decker JL. Androgenic status of males with systemic lupus erythematosus. Arthritis Rheum 1978; 21: 665-668.
4. Oktenli C, Yesilova Z, Kocar IH, Musabak U, Ozata M, Inal A, et al. Study of autoimmunity in Klinefelter's syndrome and idiopathic hypogonadotrpohichypogonadism. J Clin Immunol 2002; 22: 137-143.
5. Mok CC, Lau CS. Profile of sex hormones in male patients with systemic lupus erythematosus. Lupus 2000; 9: 252-257.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
7. Lee CK, Koh JH, Cha HS. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
8. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
9. Stefanidou S, Benos A, Galanopoulou V, Chatziyannis I, Kanakoudi F, Aslanidis S, et al. Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male: female comparison. Lupus 2011; 20: 1090-1094.
10. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995; 4: 109-115.
11. Carbone LD, Lohr KM. Ethnic differences in male lupus. J Clin Rheumatol 2002; 8: 239-240.
12. Ward MM. Laboratory abnormalities at the onset of treatment of end-stage renal disease. Arch Intern Med 2007; 167: 1083-1091.
13. Specker C, Beeker A, Lakomek HJ, Bach D. Systemic lupus erythematosus in men, a different prognosis? Z Rheumatol 1994; 53: 339-345.
14. Jönsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002; 41: 1308-1312.
15. Soto ME, Vallejo M, Guillen F, Simon JA, Arena E, Reyes PA. Gender impact in systemic lupus erythematosus. Clin Exp Rheumatol 2004; 22: 713-721.
16. Verthelyi D, Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in on-autoimmune mice. J Autoimmun 1997; 10: 115-125.
17. Sanchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1997; 40: 804-808.
18. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007; 56: 1251-1262.
19. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum 2002; 46: 1830-1839.
20. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11: 352-356.
21. Zandman-Goddard G, Solomon M, Barzilai A, Shoenfeld Y. Lupus erythematosus tumidus induced by sex reassignment surgery. J Rheumatol 2007; 34: 1938-1940.
22. Letchumanan P, Thumboo J. Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review. Semin Arthritis Rheum 2011; 40: 298-306.
23. Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus. J Pineal Res 2008; 45: 204-211.
24. Chuang E, Molitch ME. Prolactin and autoimmune diseases in humans. Acta Biomed 2007; 78 (Suppl 1): 255-261.
25. Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005; 101: 123-143.
26. Grimaldi CM, Hill L, Xu X, Peeva E, Diamond B. Hormonal modulation of B cell development and repertoire selection. Mol Immunol 2005; 42: 811-820.
27. Singh RP, Charles CS, Grossman J. Quantitative and functional gender-biased differences in regulatory and CD8+ suppressor T cells in SLE patients. Arthritis Rheum 2008; 58: S839-S840.